InfuSystems Holdings Price to Sales Ratio 2010-2023 | INFU
Historical PS ratio values for InfuSystems Holdings (INFU) over the last 10 years. The current P/S ratio for InfuSystems Holdings as of April 18, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| InfuSystems Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-18 | 7.79 | 1.36 | |
| 2023-09-30 | 9.64 | $5.73 | 1.68 |
| 2023-06-30 | 9.63 | $5.54 | 1.74 |
| 2023-03-31 | 7.75 | $5.38 | 1.44 |
| 2022-12-31 | 8.68 | $5.22 | 1.66 |
| 2022-09-30 | 6.99 | $5.09 | 1.37 |
| 2022-06-30 | 9.63 | $5.11 | 1.89 |
| 2022-03-31 | 9.80 | $4.92 | 1.99 |
| 2021-12-31 | 17.03 | $4.73 | 3.60 |
| 2021-09-30 | 13.03 | $4.67 | 2.79 |
| 2021-06-30 | 20.79 | $4.54 | 4.58 |
| 2021-03-31 | 20.36 | $4.61 | 4.41 |
| 2020-12-31 | 18.78 | $4.58 | 4.10 |
| 2020-09-30 | 12.82 | $4.49 | 2.86 |
| 2020-06-30 | 11.54 | $4.36 | 2.64 |
| 2020-03-31 | 8.49 | $4.12 | 2.06 |
| 2019-12-31 | 8.53 | $3.97 | 2.15 |
| 2019-09-30 | 5.29 | $3.75 | 1.41 |
| 2019-06-30 | 4.30 | $3.51 | 1.22 |
| 2019-03-31 | 5.01 | $3.28 | 1.53 |
| 2018-12-31 | 3.44 | $3.07 | 1.12 |
| 2018-09-30 | 3.25 | $3.08 | 1.05 |
| 2018-06-30 | 3.55 | $3.05 | 1.16 |
| 2018-03-31 | 2.90 | $3.07 | 0.94 |
| 2017-12-31 | 2.30 | $3.13 | 0.74 |
| 2017-09-30 | 2.05 | $3.04 | 0.67 |
| 2017-06-30 | 1.75 | $3.02 | 0.58 |
| 2017-03-31 | 2.30 | $3.06 | 0.75 |
| 2016-12-31 | 2.55 | $3.07 | 0.83 |
| 2016-09-30 | 2.78 | $3.15 | 0.88 |
| 2016-06-30 | 2.60 | $3.20 | 0.81 |
| 2016-03-31 | 3.52 | $3.16 | 1.11 |
| 2015-12-31 | 3.02 | $3.11 | 0.97 |
| 2015-09-30 | 2.76 | $3.01 | 0.92 |
| 2015-06-30 | 3.19 | $2.94 | 1.08 |
| 2015-03-31 | 2.71 | $2.93 | 0.92 |
| 2014-12-31 | 3.15 | $2.96 | 1.07 |
| 2014-09-30 | 3.14 | $3.01 | 1.04 |
| 2014-06-30 | 2.65 | $2.99 | 0.89 |
| 2014-03-31 | 2.78 | $2.92 | 0.95 |
| 2013-12-31 | 2.14 | $2.82 | 0.76 |
| 2013-09-30 | 1.28 | $2.80 | 0.46 |
| 2013-06-30 | 1.49 | $2.73 | 0.54 |
| 2013-03-31 | 1.74 | $2.73 | 0.64 |
| 2012-12-31 | 1.50 | $2.75 | 0.55 |
| 2012-09-30 | 1.76 | $2.66 | 0.66 |
| 2012-06-30 | 1.89 | $2.70 | 0.70 |
| 2012-03-31 | 1.94 | $2.66 | 0.73 |
| 2011-12-31 | 1.61 | $2.59 | 0.62 |
| 2011-09-30 | 0.95 | $2.57 | 0.37 |
| 2011-06-30 | 2.16 | $2.47 | 0.87 |
| 2011-03-31 | 2.70 | $2.35 | 1.15 |
| 2010-12-31 | 2.33 | $2.32 | 1.01 |
| 2010-09-30 | 2.50 | $2.20 | 1.14 |
| 2010-06-30 | 2.55 | $2.10 | 1.22 |
| 2010-03-31 | 2.45 | $2.09 | 1.17 |
| 2009-09-30 | 2.15 | $2.08 | 1.04 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.167B | $0.126B |
| InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Stryker (SYK) | United States | $127.849B | 31.70 |
| Medtronic (MDT) | Ireland | $105.004B | 14.86 |
| Boston Scientific (BSX) | United States | $99.704B | 33.15 |
| EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
| ResMed (RMD) | United States | $25.568B | 25.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
| Terumo (TRUMY) | Japan | $24.880B | 35.14 |
| Baxter (BAX) | United States | $20.069B | 14.64 |
| Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
| Insulet (PODD) | United States | $11.642B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
| Demant (WILYY) | Denmark | $10.001B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
| BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
| Perrigo (PRGO) | Ireland | $4.071B | 11.64 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.378B | 15.97 |
| Envista Holdings (NVST) | United States | $3.367B | 12.80 |
| Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
| ICU Medical (ICUI) | United States | $2.336B | 17.43 |
| TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| Owens & Minor (OMI) | United States | $1.836B | 17.62 |
| Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
| InMode (INMD) | Israel | $1.465B | 7.59 |
| LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
| AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
| Warby Parker (WRBY) | United States | $1.189B | 0.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| MacroGenics (MGNX) | United States | $1.007B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
| BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
| Evolus (EOLS) | United States | $0.674B | 0.00 |
| Jin Medical (ZJYL) | China | $0.631B | 0.00 |
| Quanterix (QTRX) | United States | $0.602B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.538B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
| PetIQ (PETQ) | United States | $0.469B | 17.50 |
| ZimVie (ZIMV) | United States | $0.417B | 25.55 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.388B | 44.70 |
| Surmodics (SRDX) | United States | $0.378B | 40.80 |
| Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
| Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
| Veru (VERU) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Fonar (FONR) | United States | $0.105B | 8.98 |
| Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Safety Shot (SHOT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
| ProSomnus (OSA) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |